Updated:
Checkmate Pharmaceuticals, Inc.
Checkmate Pharmaceuticals, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001651431, and its reported...
Overview
Checkmate Pharmaceuticals, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001651431, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2022-03-30, it reported net income of USD -61,405,000; total assets of USD 78,838,000 for the fiscal period ended 2021-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Checkmate Pharmaceuticals, Inc.
- Classification
- Company
- Industry (SIC)
- 2836 — Biological Products, (No Diagnostic Substances)
- Headquarters
- Cambridge, MA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001651431
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|
| FY2021USD | -$61.4M | $78.8M | $50.7M | -$53.7M | |
| FY2020USD | -$36.9M | $133.1M | $43.1M | -$38.1M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| SC 13D | — | SCHEDULE 13D - CHECKMATE PHARMACEUTICALS, INC. | |
| 8-K | FORM 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 10-K/A | 10-K/A | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-K | 10-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| SC 13G | — | SC 13G | |
| 8-K | 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Checkmate Pharmaceuticals, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.